CLINICAL AND PROGNOSTIC SIGNIFICANCE OF LIVER FUNCTIONAL RESERVES EVALUATION CRITERIA FOR LIVER DISEASES AND RESECTIONS | Issues of reconstructive and plastic surgery. 2014. № 4 (51).

CLINICAL AND PROGNOSTIC SIGNIFICANCE OF LIVER FUNCTIONAL RESERVES EVALUATION CRITERIA FOR LIVER DISEASES AND RESECTIONS

In the literary review presented state of the problem selecting prognostic criteria for evaluating liver functional reserves when performing resection of liver. The main risk factors is the presence of liver disease, a small amount of the remaining liver. Focuses on the importance of comprehensive pre-operative evaluation, which includes clinical, biochemical, solid and functional data. Preventive measures are most effective when they are used at all stages of case management.

Download file

Counter downloads: 391

Keywords

risk factors, functional reserves of liver, resection of liver, факторы риска, печеночная недостаточность, функциональные резервы печени, резекция печени, liver failure

Authors

Name	Organization	E-mail
Krasnov O. A.
Pavlenko V. V.		pavlenkovv@list.ru
Krasnov A. O.

Всего: 3

References

Sen S., Williams R., Jalan R. The pathofhysiological basis of acute-on-chronic liver failure // Liver. - 2002. - № 22 (Suppl. 2). - P. 5-13.

Shoup M., Gonen M., D’Angelica M., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection // J. Gastrointest. Surg. - 2003. - № 7. - P. 325-330.

Speich R., Saesseli B., Hoffmann U. et al. Anaphylactoid reactions after indocyanine-green administration // Annals of Internal Medicine. - 1988. - V. 109. - P. 345-346.

Schroter J., Wandel C., Bohrer H., Schmidt H., Bottiger B. W., Martin E. Lignocaine metabolite formation: an indicator for liver dysfunction and predictor of survival in surgical intensive care patients // Anaesthesia. - 1995. - V. 50. - P. 850-854.

Sakuhara Y., Abo D., Hasegawa Y., Shimizu T., Kamiyama T., Hirano S., Fukumori D., Kawamura T., Ito Y. M., Tha K. K., Shirato H., Terae S. Preoperative percutaneous transhepatic portal vein embolization with ethanol injection // AJR Am. J. Roentgenol. - 2012. - Apr; 198 (4). - P. 914-922.

Saadeh S., Behrens P. W., Parsi M. A., Carey W. D., Connor J. T., Grealis M., Barnes D. S. The utility of 13C-galactose breath test as a measure of liver function // Aliment. Pharmacol. Ther. - 2003. - V. 18. - P. 995-1002.

Rocco A., de Nucci G., Valente G., Compare D., D'Arienzo A., Cimino L., Perri F., Nardone G. 13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C // J. Hepatol. - 2012. - Apr; 56 (4). - P. 782-787.

Oellerich M., Burdelski M., Lautz H.U., Binder L., Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis // Hepatology. - 1991. - Dec; 14 (6). - P. 1029-1034.

Oellerich M., Burdelski M., Lautz H. U. et al. Assessment of pretransplant prognosis in patients with cirrhosis // Transplantation. - 1991. - V. 51. - P. 801-806.

Oellerich M., Hartmann H., Ringe B. et al. Assessment of prognosis transplant candidates by use of the Pugh- MEGX score // Transpl. Proc. - 1993. - V. 25. - P. 1116-1119.

Piscaglia F., Donati G., Serra C. et al. Value of splanchnic Doppler ultrasound in the diagnosis of portal hypertension // Ultrasound Med. Biol. - 2001. - V. 27. - P. 893-899.

Oellerich M., Burdelski M., Lautz H. U., Schulz M., Schmidt F. W., Herrmann H. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis // Ther. Drug. Monit. - 1990. - May; 12 (3). - P. 219-226.

Navasa M., Garcia-Pagan J. C., Bosch J., Rodes J. Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices // Med. Clin. (Barc). - 1992. - V. 98. - P. 290-294.

Nonami T., Nakao A., Kurokawa T. et al. Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure // Hepatogastroenterology. - 1999. - V. 46 (27). - P. 1669-1672.

Oellerich M., Raude E., Burdelski M., Schulz M., Schmidt F. W. Monoethylglycinexylidide formation kinetics: A novel approach to assessment of liver function // J. Clin. Chem. Clin. Biochem. - 1987. - V. 25. - P. 845-853.

Mеrkel C., Bolognesi M., Bellon S. et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis // Gut. - 1992. - V. 33. - P. 836-842.

Mukherjee S., Rogers M. A., Buniak B. Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis // Hepatogastroenterology. - 2006. - V. 53. - P. 1203.

Mullin E. J., Metcalfe M. S., Maddern G. J. How much liver resection is too much? // Am. J. Surg. - 2005. - V. 190 (1). - P. 87-97.

Merkel C., Gatta A., Zoli M. et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score // Dig. Dis. Sci. - 1991. - V. 36. - P. 1197-1203.

Malinchoc M., Kamath P. S., Gordon F. D., Peine C. J., Rank J., ter Borg P. C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts // Hepatology. - 2000. - Apr; 31(4). - P. 864-871.

Maruyama S., Hirayama C., Yamamoto S. et al. Hyperendothelinemia and ICG clearance in alcoholic and nonalcoholic cirrhosis // Dig. Dis. Sci. - 2002. - V. 47. - P. 773-777.

Matsumoto K., Suehiro M., Iio M., Shiratori Y., Okano K., Sugimoto T. 13C-Methacetin breath test for evaluation of liver damage // Dig. Dis. Sci. - 1987. - V. 32. - P. 344-348.

Merkel C., Bolognesi M., Finucci G. F. et al. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis // J. Hepatol. - 1989. - № 9. - P. 16-22.

Lucey M.R., Brown K.A., Everson G.T., Fung J.J., Gish R., Keefe E.B., Kneteman N.M., Lake J.R., Martin P., Rakela J., Shiffman M.L., So S., Wiesner R.H. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases // Transplantation. - 1998. - Oct. 15; 66 (7). - P. 956-962.

Lalazar G., Adar T., Ilan Y. Point-of-care continuous (13) C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial // World J. Gastroenterol. - 2009. - Feb 28;15 (8). - P. 966-972.

Lee S. G., Hwang S. How I do it: assessment of hepatic functional reserve for indication of hepatic resection // J. Hepatobiliary Pancreat. Surg. - 2005. - V. 12 (1). - P. 38-43.

Li Y. M., Lv F., Xu X. Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume // World J. Gastroenterol. - 2003. - № 9. - P. 2092-2095.

Kobayashi T., Kubota K., Imamura H. et al. Hepatic phenylalanine metabolism measured by the [13C] phenylalanine breath test // Eur. J. Clin. Invest. - 2001. - V. 31. - P. 356-361.

Kubota K., Makuuchi M., Kusaka K. et al. Measurement of liver volume and hepatic functional reserve as a guide to decisionmaking in resectional surgery for hepatic tumors. // Hepatology. - 1997. - V. 26. - P. 1176-1181.

Herold C., Heinz R., Radespiel-Troger M., Schneider H.T., Schuppan D., Hahn E.G. Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity // Liver. - 2001. - Feb; 21 (1). - P. 26-30.

Imamura H., Sano K., Sugawara Y., Kokudo N., Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test // J. Hepatobiliary Pancreat. Surg. - 2005. - V. 12 (1). - P. 16-22.

Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., D'Amico G., Dickson E.R., Kim W.R. A model to predict survival in patients with end-stage liver disease // Hepatology. - 2001. - Feb; 33 (2). - P. 464-4470.

Helling T. Liver failure following partial hepatectomy // HPB. - 2006. - V. 8. - P. 165-174.

Hemming A.W., Scudamore C.H., Shackleton C.R. et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhosis patients // Am. J. Surgery. - 1992. - V. 163. - P. 515-518.

Groszmann R.J. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences // Hepatology. - 1994. - Nov; 20 (5). - P. 1359-1363.

Hashimoto M., Watanabe G. Hepatic parenchymal cell volume and the indocyanine green tolerance test // J. Surg. Res. - 2000. - V. 92. - P. 222-227.

Guglielmi A., Ruzzenente A., Conci S., Valdegamberi A., Iacono C. How much remnant is enough in liver resection? // Dig. Surg. - 2012. - V. 29 (1). - P. 6-17.

Giannini E. G., Fasoli A., Borro P. et al. 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease // Clin. Gastroenterol. Hepatol. - 2005. - № 3. - P. 279-285.

Gindro T., Arrigoni A., Martinasso G., Rosina F., Perardi S., Cappello N., Benedetti P., Actis G. C., Verme G., Rizzetto M. Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score // Eur. J. Gastroenterol. Hepatol. - 1997. - Dec; 9 (12). - P. 1155-1159.

Gremse A., a-Kader H., Schroeder T. J., Balistreri W. F. Assessment of lidocaine metabolite formation as a quantitative liver function test in children // Hepatology. - 1990. - V. 12. - Р. 565-569.

Garello E., Battista S., Bar F. et al. Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations // Dig. Dis. Sci. - 1999. - V. 4. - P. 782-788.

Festi D., Capodicasa S., Sandri L. et al. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: Comparison with Child-Pugh score and serum bile acid levels // World J. Gastroenterol. -2005. - V. 11, № 1. - P. 142-148.

Fazakas J., Mandli T., Ther G. et al. Evaluation of Liver function for hepatic resection // Transplant. Proc. - 2006. - V. 38. - P. 798-800.

Fausto N. Liver regeneration // J. Hepatol. - 2000. - V. 32. - P. 19-31.

Faybik P., Hetz H. Plasma disappearance rate of indocyanine green in liver dysfunction // Transplant Proc. - 2006. - V. 38. - P. 801-802.

Figg W.D., Dukes G.E., Lesesne H.R., Carson S.W. Comparison of quantitative methods to assess hepatic function: Pugh’s classification, indocyanine green, antipyrine, and dextromethorphan // Pharmacotherapy. - 1995. - V. 15. - P. 693-700.

Fausto N., Kampbell J. S., Riehle K. J. Liver regeneration // Hepatology. - 2006. - V. 43. - P. 45-53.

Eguchi H., Umeshita K., Sakon M., Nagano H., Ito Y., Kishimoto S.I., Dono K., Nakamori S., Takeda T., Gotoh M., Wakasa K., Matsuura N., Monden M. Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure // Dig. Dis. Sci. - 2000. - Jul, 45 (7). - P. 383-1388.

Ercolani G., Grazi G., Calliva R. et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery // Surgery. - 2000. - V. 127. - P. 464-471.

Eroglu A., Demirci S., Akbulut H. et al. Effect of granulocyte-macrophage colony-stimulating factor on hepatic regeneration after 70% hepatectomy in normal and cirrhotic rats // HPB. - 2002. - V. 4, № 2. - P. 67-73.

Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? // J. Hepatol. - 2004. - Aug; 41(2). - P. 344-350.

Degre D., Bourgeois N., Boon N. et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation // Transpl. Int. - 2004. - V. 17. - P. 31-38.

Desaj N.M., Mange K.C., Crawford M.D. et al. Predicting outcome after liver transplantation: utility of the Model for end-stage liver disease and a nevly derived discrimination function // Transplantation. - 2004. - V. 77. - Р. 99-106.

Burke P.A., Stack J.A., Wagner D., Lewis D.W., Jenkins R.L., Forse R.A. 13C-Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease // Am. J. Surg. - 1997. - V. 173. - № 4. - Р. 270-273.

Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E. J., Pandya P., Sitaraman S., Shen J. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding // Hepatology. - 2002. - May, 35(5). - P. 1282-1284.

Botta F., Giannini E., Romagnoli P., Fasoli A., Chiarbonello B., Testa E., Risso D., Testa R. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study // Gut. - 2003. - Jan. 52. - P. 134-139.

Brown R.S. Jr., Kumar K.S., Russo M.W. Model for end-stage disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients // Liver Transplantation. - 2002. - V. 8 (3). - P. 278-284.

Christensen E. Prognostic models in chronic liver disease: validity, usefulness and future role // J. Hepatol. - 1997. - Jun; 26 (6). - P. 1414-1424.

Belgihiti J., CIavien P. A., Gadzijev et al. The Brisbane 2000 terminology of liver anatomy and resections // HPB. - 2000. - V. 2. - P. 333-339.

Bennink R.J., Dinant S., Erdogan D. et al. Preoperative assessment of postoperative remnantliver function using hepatobiliary scintigraphy // J. Nucl. Med. - 2004. - V. 45 (6). - P. 965-971.

Behrns K. E., Tsiotos G. G., DeSouza N. F., Krishna M. K., Ludwig J., Nagorney D. M. Hepatic steatosis as a potential risk factor for major hepatic resection // J. Gastrointest. Surg. - 1998. - № 2 (3). - P. 292-298.

Albers I., Hartmann H., Bircher J., Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis // Scand. J. Gastroenterol. - 1989. - V. 24. - P. 269-276.

Barbare J.C., Poupon R.E., Jaillon P. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis // J. Hepatol. - 1985. - № 1. - P. 253-259.

Ермолов А. С., Гуляев В. А., Чжао А. В., Сечкин А. В., Журавель С. В., Джаграев К. Р., Погребниченко И. В., Кузнецова Н. К. Актуальные вопросы органного донорства // Рос. мед. журн. - 2005. - № 4. - С. 3-8.

Патютко Ю. И. Хирургическое лечение злокачественных опухолей печени. М.: Практическая медицина, 2005. - 312 с.

Хазанов А. И., Некрасова Н. Н. Усовершенствование системы Child-Pugh в целях повышения точности прогноза цирроза печени // Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. - 2002. - № 2. - С. 16-20.

Adedoyou A., Branch R.A. Pharmacokinetics. In: D. Zakin, T.D. Boyer (eds.). Hepatology: a textbook of liver Disease. 3rd ed. Philadelphia: W. B. Saunders, 1996. - P. 311-313.

Adler M., Verset D., Bouhdid H., Bourgeois N., Gulbis B., Le Moine O., Van de Stadt J., Gelin M., Thiry P. Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score // J. Hepatol. 1997. - Mar; 6 (3). - P. 642-649.

Шеммер П., Фрисс X., Бюхлер М. В. Последние разработки в хирургическом лечении первичного и метастатического рака печени // Анналы хирургической гепатологии. - 2002. - Т. 7, № 2. - С. 114-123.

Гальперин Э. И. Регенерация печени при массивных ее резекциях и повреждениях // Анналы хирургической гепатологии. - 2002. - Т. 7, № 1. - С. 279.

Вишневский В. А., Кубышкин В. А., Чжао А. В., Икрамов Р. З. Операции на печени: Рук. для хирургов. - М.: Миклош, 2003. - 153 с.